Airsonett standing over a bed

This is how simple it is

Illustration - allergen exposure
Allergen exposure is high during sleep
Illustration - clean air
Airsonett® Air4 provides 99.5% clean air in the breathing zone
Illustration - sleeping
Your body has the opportunity to rest and recharge
nothing but clean air
clean air
Users

Is Air4

right for me?

Whether you are looking to improve your symptoms or want to benefit from perfectly clean air while you sleep, take 2 minutes to find out if the Air4 is right for you.

Click to find out
Doctor and child
PHYSICIANS

Is the Air4 right for my patient

Help your patients to improved health with the Air4. We’ll help you quickly identify if the Air4 is right for your patients’ conditions.

Learn more

Why Air4? It works

Airsonnet Graph

100 times more efficient than air purifiers

Airsonnet Graph

Instead of trying to clean your entire room with an air purifier, the Air4 uses TLA (temperature-controlled laminar airflow) technology to provide perfectly clean air to your breathing zone while you sleep while also lowering the overall particle exposure in the room.

Only with the Air4, particles such as allergens, dust, bacteria, pollen, pet dander, viruses and other airborne particles are all eliminated, leaving nothing but clean air to breathe while you sleep.

Reference: Spilak M, et al. A comparison between temperature controlled laminar airflow device and a room-air cleaner in reducing exposure to particles while asleep. PLoS ONE 2016;11(11): e0166882.

hand
Easy to use Just plug it in and switch it on when you are ready to sleep
document
Proven Efficiency through verified clinical evidence
safe
Safe No pharmacological side effects
Handshake
Trusted CE marked and registered medical device as proof of quality and reliability
Woman enjoying sleeping
Sharon
United Kingdom
“My little lifesaver that hums gently next to me as I sleep”

Ready to find out if the Air4 is right for you?

Find out

So what do we mean by

perfectly clean air?

Air4 filters out 99.5% of all particles greater than 0.5 microns.
The test results are the proof.
Air sonnet on white background
Purchase the Air4

Ready to experience the positive effects of perfectly clean air?

I want one

News

Read the latest news on Airsonett and see where you can meet us at tradeshows or demo events.

Airsonett AIR4 maintains good control of severe allergic asthma after withdrawal of omalizumab July 11, 2018

An independent study by Professor C. Wang concludes in the title of the study “A nocturnal temperature controlled laminar flow device (TLA) maintains good control of severe allergic asthma(SAA) after withdrawal of Omalizumab therapy”. The study will be published in a poster session at ERS on Asthma Management session on Sunday 16 September 2018.

“We are naturally very positive to these interesting data and look forward to feedback from the health care sector” says Anders Due-Boje, CEO at Airsonett AB.

Airsonett AB is a medical device company with a unique technology developed to treat patients with severe asthma. The company is active in Europe, the US and recently signed a major co-operation agreement with a Chinese distributor. The company’s product Airsonett AIR4 is a clinically validated, non-pharmaceutical treatment of asthma, which reduces allergens and other airborne irritants from the patient’s breathing zone during the nightly sleep.

Airsonett AB announces that the company has appointed Anders Due-Boje as its new CEO July 4, 2018

Airsonett AB is a medical device company with a unique technology developed to treat patients with severe asthma. The company is active in Europe, the US and recently signed a major co-operation agreement with a Chinese distributor. The company’s product Airsonett AIR-4 is a clinically validated, non-pharmaceutical treatment of asthma, which reduces allergens and other airborne irritants from the patient’s breathing zone during the nightly sleep.

Anders Due-Boje took up his position as CEO in 18 June. Anders has experience in developing both SME’s and larger corporations on a global level in the Medical Device and Information Industry and he has a strong sales and marketing focus. Anders has had leading positions within various companies, among others Neoventa Medical, GN Netcom och Motorola.

“Anders has more than 25 years’ international experience from management positions in the Medical Device and Information industry and he will be able to assist the company to take the next step in a successful development” says Magnus Lundberg, Chairman at Airsonett AB.

Airsonett recently signed agreement with distributor in Germany April 26, 2018

“Germany is one of our key markets so we are pleased to have signed a distribution agreement with the medical device company OxyCare GmbH. The company is dedicated to promote and launch Airsonett AIR4 on the German market. OxyCare will not only market AIR4 but also handling all logistics,installations and training for the German market. We are very pleased that we now have a partner that can introduce the AIR4 in Germany and help more people benefit from this treatment.” says Jonas Båghammar, VP Business Development at Airsonett AB.

Airsonett AB is a medical device company with a unique technology developed to treat patients with severe allergic asthma or eczema. The company is active in Europe, the US and recently signed a major co-operation agreement with a Chinese distributor. The company’s product Airsonett AIR4 is a clinically validated, non-pharmaceutical treatment, which reduces allergens and other airborne irritants from the patient’s breathing zone during the nightly sleep.

News
We use cookies to enhance your experience of our website. To view our privacy policy click here
I accept Cancel